Placental pathology in COVID-19
Objectives To describe histopathologic findings in the placentas of women with coronavirus
disease 2019 (COVID-19) during pregnancy. Methods Pregnant women with COVID-19 …
disease 2019 (COVID-19) during pregnancy. Methods Pregnant women with COVID-19 …
Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy
Objective Vaccination of pregnant women can be an important strategy to confer protection
to neonates and young infants.
to neonates and young infants.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in pregnancy: measures of immunity and placental histopathology
METHODS The study methods have been described previously and were approved by the
Northwestern University institutional review board. 7, 15 We report results from patients who …
Northwestern University institutional review board. 7, 15 We report results from patients who …
Neuropathology of anti-amyloid-β immunotherapy: a case report
RJ Castellani, ED Shanes, M McCord… - Journal of …, 2023 - content.iospress.com
Host responses to anti-amyloid-β (Aβ) antibody therapy are evident in neuroimaging changes
and clinical symptoms in a subset of clinical trial subjects receiving such therapy. The …
and clinical symptoms in a subset of clinical trial subjects receiving such therapy. The …
Placental pathology after SARS-CoV-2 infection in the pre-variant of concern, alpha/gamma, delta, or omicron eras
Objectives. The goal of this study is to describe placental pathology after infection with SARS-CoV-2
before the predominance of variants of concern (pre-VOC) and during eras of …
before the predominance of variants of concern (pre-VOC) and during eras of …
Maternal antibody response and transplacental transfer following severe acute respiratory syndrome coronavirus 2 infection or vaccination in pregnancy
…, ES Miller, A Sunderraj, ED Shanes… - Clinical Infectious …, 2023 - academic.oup.com
Background Pregnant persons are at increased risk of severe coronavirus disease 2019 (COVID-19)
and adverse obstetric outcomes. Understanding maternal antibody response, …
and adverse obstetric outcomes. Understanding maternal antibody response, …
Low-level SARS-CoV-2 viremia coincident with COVID placentitis and stillbirth
SARS-CoV-2 infection in pregnancy and COVID placentitis are associated with an increased
risk of stillbirth. We sought to investigate the presence of maternal viremia in people with …
risk of stillbirth. We sought to investigate the presence of maternal viremia in people with …
PD-L1 expression and tumor-infiltrating lymphocytes in uterine smooth muscle tumors: implications for immunotherapy
ED Shanes, LA Friedman, AM Mills - The American journal of …, 2019 - journals.lww.com
Immunotherapies targeting the PD-1/PD-L1 checkpoint axis are of growing interest for the
treatment of mesenchymal neoplasms. However, PD-L1 expression and tumor-associated …
treatment of mesenchymal neoplasms. However, PD-L1 expression and tumor-associated …
Mucinous ovarian tumors
AM Mills, ED Shanes - Surgical pathology clinics, 2019 - surgpath.theclinics.com
Ovarian mucinous tumors range from benign cystadenomas to borderline tumors to frankly
malignant adenocarcinomas, and may display either intestinal-type morphology or, less …
malignant adenocarcinomas, and may display either intestinal-type morphology or, less …
Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy
Background Pregnant persons are at increased risk of severe COVID-19 and adverse obstetric
outcomes. Understanding maternal antibody response and transplacental transfer after …
outcomes. Understanding maternal antibody response and transplacental transfer after …